| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42d09f1d32f6494531c696ea59219b0d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883 |
| filingDate |
2019-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1ed6e1e0d95fe20bb92e1e7bd89a8b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_284775afeb7ebb36bdd28f1303f21844
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29804726baca29de414cf335a5c37765 |
| publicationDate |
2019-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-110184336-A |
| titleOfInvention |
Application of folate receptor FOLR2 and its encoding gene |
| abstract |
The invention discloses the application of folate receptor FOLR2 and its encoding gene as biomarkers in preparing products for diagnosing neurological Lyme disease or preparing medicines for treating neurological Lyme disease. The clinical diagnosis and treatment of neurological Lyme disease have not yet been fully clarified. Therefore, the specific high expression of FOLR2 in neurological Lyme disease is of great significance for the diagnosis, treatment and pathogenesis of the disease. |
| priorityDate |
2019-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |